News tagged with amgen
Topical use of arthritis drug provides relief for dry eye disease
Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life. An estimated nine million people ...
Ophthalmology
Apr 18, 2013 |
4 / 5 (1) |
0
Web-based nephrology consults may reduce referrals
(HealthDay)—A system of Web-based consultations (telenephrology) may reduce the number of specialty referrals for patients with chronic kidney disease, according to a study published in the March/April ...
Health
Apr 04, 2013 |
not rated yet |
0
Novel Amgen virus-vaccine shrinks melanoma tumors
Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.
Cancer
Mar 20, 2013 |
not rated yet |
0
Study shows anemia drug does not improve health of anemic heart failure patients
Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Top US court allows Amgen class action suit
The US Supreme Court ruled Wednesday in favor of investors seeking to join a class-action lawsuit against pharmaceutical giant Amgen for downplaying safety concerns about two anemia drugs.
Medications
Feb 28, 2013 |
not rated yet |
0
US halts Amgen study after teen patient death (Update)
U.S. government health regulators have halted Amgen's studies of its drug Sensipar after the death of a 14-year-old patient in a company trial.
Medications
Feb 26, 2013 |
not rated yet |
0
Amgen 4Q profit drops 16 pct. on higher spending
Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results ...
Other
Jan 23, 2013 |
not rated yet |
0
Amgen to pay record $762 mn fine over anemia drug (Update)
US pharmaceutical giant Amgen has pleaded guilty to illegally introducing a mislabeled drug for treating anemia onto the market and will pay a record $762 million fine, officials said Wednesday.
Medications
Dec 18, 2012 |
5 / 5 (1) |
0
Amgen buying deCODE Genetics for $415 million
Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.
Genetics
Dec 10, 2012 |
not rated yet |
0
New treatment aids weight loss, improves diabetes in monkeys
(HealthDay)—A new, lab-created antibody that mimics the action of a naturally occurring molecule causes weight loss in monkeys, researchers report.
Medical research
Nov 28, 2012 |
5 / 5 (5) |
0
|
Envisioning novel approaches for eye disease: 'The new medicine' at UC Santa Barbara
By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells –– a synthetic patch akin to a contact lens –– as a treatment ...
Medical research
Oct 16, 2012 |
5 / 5 (1) |
0
Gene score IDs prognosis in metastatic neuroblastoma
(HealthDay)—For children with metastatic MYCN-nonamplified neuroblastoma (NBL-NA) diagnosed at age 18 months or older, increased expression of tumor-associated inflammatory genes seems to correlate with p ...
Cancer
Aug 29, 2012 |
5 / 5 (1) |
0
Researchers discover way to block body's response to cold
Researchers at St. Joseph's Hospital and Medical Center in Phoenix, Arizona, in collaboration with Amgen Inc. and several academic institutions, have discovered a way to block the body's response to cold using a drug. This ...
Neuroscience
Mar 01, 2012 |
5 / 5 (1) |
0
|